Please use this identifier to cite or link to this item: https://doi.org/10.1076/soph.17.2.79.14717
Title: Medical management of angle closure glaucoma
Authors: Hoh, S.-T.
Aung, T.
Chew, P.T.K. 
Keywords: Adrenergic agonist
Glaucoma
Intraocular pressure
Narrow angle
Pharmacology
Prostaglandin
Pupil block
Issue Date: Jun-2002
Source: Hoh, S.-T.,Aung, T.,Chew, P.T.K. (2002-06). Medical management of angle closure glaucoma. Seminars in Ophthalmology 17 (2) : 79-83. ScholarBank@NUS Repository. https://doi.org/10.1076/soph.17.2.79.14717
Abstract: Management of angle closure glaucoma requires an understanding of the underlying pathophysiologic mechanisms. Treatment is aimed at eliminating pupillary block and other causes of angle closure, re-opening the angle, and preventing further damage to the optic nerve by lowering intraocular pressure. Medical therapy plays an important role in the successful management of this condition. This article describes commonly used pharmacologic agents, as well as newer classes of drugs such as topical carbonic anhydrase inhibitors, prostaglandin analogues and selective alpha2-adrenergic agonists. Use of these drugs in several clinically distinct angle closure syndromes and modes of presentation are discussed.
Source Title: Seminars in Ophthalmology
URI: http://scholarbank.nus.edu.sg/handle/10635/92624
ISSN: 08820538
DOI: 10.1076/soph.17.2.79.14717
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

6
checked on Feb 21, 2018

Page view(s)

25
checked on Feb 24, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.